Aditya Puri joins as director of Stelis Biopharma
Strides Pharma Science Limited is pleased to announce that Aditya Puri joins the Strides Group as an Advisor and also will be a Director of its associate Company, Stelis Biopharma.
Strides Pharma Science Limited is pleased to announce that Aditya Puri joins the Strides Group as an Advisor and also will be a Director of its associate Company, Stelis Biopharma.
The upgraded Rajajipuram centre now features enhanced retina services and advanced OCT technology
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
Hair care & quick commerce shine
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
Subscribe To Our Newsletter & Stay Updated